SEC Form 4 · accession 0001104659-15-068329
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bernard Denoyer
Officer — Senior Vice President, Finance
Period of report
Sep 29, 2015
Accepted (ET)
Sep 30, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $5.39 | Sep 29, 2015 | A | 100,000 | A | — | Sep 29, 2025 | Common Stock | 100,000 | 841,017 | D |
Explanation of responses
- F133,333 stock options vest on 9/29/2016 and 2017 and 33,334 stock options vest on 9/29/2018.